This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa
The drug NEURONTIN contains one active pharmaceutical ingredient (API):
1
Gabapentin
UNII 6CW7F3G59X - GABAPENTIN
|
Gabapentin readily enters the brain and prevents seizures in a number of animal models of epilepsy. Gabapentin binds with high affinity to the α2δ (alpha-2-delta) subunit of voltage-gated calcium channels and it is proposed that binding to the α2δ subunit may be involved in gabapentin’s anti-seizure effects in animals. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NEURONTIN Capsule / Film-coated tablet / Solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
NEURONTIN Capsule, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02BF01 | Gabapentin | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1834M, 1835N, 4591P, 4592Q, 4593R, 4594T, 4595W, 8389M, 8505P, 8559L |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 552820050067217, 552820050067317, 552820050067417, 552820050067517 |
Country: CA | Health Products and Food Branch | Identifier(s): 02084260, 02084279, 02084287, 02239717, 02239718 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00257176, 00310054, 00310060, 00310108, 00323163, 00323200, 00323217, 00326747, 00326776, 01260594, 01260619, 01344546, 01344552, 01415660, 01677213, 02213800, 03995733, 03996684, 04857789, 06165914, 07153907, 07153936, 07153942, 07153971, 07698564, 09235012, 09252364, 10058615, 10058621, 10058638, 10058644, 13911045, 13911051 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 28985-08-09, 28995-09-09 |
Country: EE | Ravimiamet | Identifier(s): 1032815, 1076969, 1353316, 1353327, 1353338, 1353349, 1353350, 1353372, 1353383, 1353394, 1618455, 1826355, 1839146, 1839168, 1839180, 1845547 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 60621, 60622, 63149, 63150 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 097790, 097816, 495572, 495580, 502724 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61022591, 61401189, 62283270, 62678755, 63308221, 64191283, 65758562, 66043963, 67298504 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 178845, 180587, 210595, 21730, 21743, 21755, 21775, 21783, 381554, 381556 |
Country: HK | Department of Health Drug Office | Identifier(s): 38406, 38407, 38408, 50065 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-198579675, HR-H-227912224 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 36207, 36254, 36269, 36359, 36390, 36455, 44539, 62154, 62167 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 3334, 3335 |
Country: IT | Agenzia del Farmaco | Identifier(s): 028740013, 028740025, 028740037, 042166013, 042166025 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003610, 1003611, 1003820, 1010255, 1010256, 1010257, 1010258, 1014509, 1020496, 1034495, 1034496, 1034497, 1034498, 1034499, 1034500, 1034501, 1034502, 1034503, 1034504, 1034505, 1034506, 1034507, 1034508, 1034509, 1034510, 1034511, 1034512, 1034513, 1034514, 1034515, 1034516, 1034517, 1034518, 1034519, 1034520, 1034521, 1034522, 1034523, 1034524, 1034525, 1034526, 1034527, 1034528, 1034529, 1034530, 1034531, 1034532, 1034533, 1068376, 1085760 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 157M95, 310M2000 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 52817, 52825, 52833, 57541, 57568 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 5035, 5036, 8475, 9582, 9583 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100041071, 100081277, 100081283, 100118738, 100118744 |
Country: SG | Health Sciences Authority | Identifier(s): 08302P, 08303P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 14573011, 2233012 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699532095527, 8699532095534, 8699756154390, 8699756154406, 8699756154413 |
Country: US | FDA, National Drug Code | Identifier(s): 0071-0401, 0071-0513, 0071-0803, 0071-0805, 0071-0806, 0071-2012, 80425-0033, 80425-0034, 80425-0035, 80425-0036, 80425-0079 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 27/2.5/0598, 27/2.5/0599, 27/2.5/0600, 35/2.5/0099, 35/2.5/0100 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.